Servier Executive: ‘We Are Not Looking for Blockbusters, We’re Looking for Innovative Science’
Servier accomplished its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular enterprise is predicted to shut ...